[YY Inc. to Hold 2016 Annual General Meeting on November 28, 2016 Guangzhou, October 11, 2016 YY Company ADSs No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will serve as an open forum for shareholders and beneficial owners of]
[CNIT Receives Withdrawal of Going Private Proposal SHENZHEN, China, October 11, 2016 -- China Information Technology, Inc. (Nasdaq: CNIT ) the Buyer Group that had on June 19, 2015 submitted a non-binding proposal to take the company private at a price of $4.43 per share has, due to the current circ]
[TAIPEI, Taiwan and MILPITAS, Calif., October 7, 2016 Silicon Motion Technology Corporation (NasdaqGS: SIMO) (Silicon Motion or the Company), a global leader in designing and marketing NAND flash controllers for solid state storage devices, announces that based upon its preliminary third quarte]
[PROXY STATEMENT OF THE COMPANY October 11, 2016 Shareholders of Sky-mobi Limited Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of Sky-mobi Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (t]
[TAIPEI, Taiwan and MILPITAS, Calif., October 7, 2016 Silicon Motion Technology Corporation (NasdaqGS: SIMO) (Silicon Motion or the Company), a global leader in designing and marketing NAND flash controllers for solid state storage devices, announces that based upon its preliminary third quarte]
[FOR RELEASE October 11, 2016 China Biologic Receives CFDA Clinical Trial Approval for Human Antithrombin III BEIJING, China – October 11, 2016 – ATIII is intended to treat hereditary and acquired ATIII deficiency in connection with surgical or obstetrical procedures, and to treat thromboembolism. No]
[EX 1 Announcement dated October 10, 2016 in respect of Mixed-ownership Reform. changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC; changes in telecommunications and related technologies and]
[FOR RELEASE October 11, 2016 China Biologic Receives CFDA Clinical Trial Approval for Human Antithrombin III BEIJING, China – October 11, 2016 – ATIII is intended to treat hereditary and acquired ATIII deficiency in connection with surgical or obstetrical procedures, and to treat thromboembolism. No]
[EX 1 Announcement dated October 10, 2016 in respect of Mixed-ownership Reform. changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC; changes in telecommunications and related technologies and]
[To Stockholders of Carmike Cinemas, Inc.: On July 24, 2016, AMC Entertainment Holdings, Inc., referred to as "AMC," entered into an Amended and Restated Agreement and Plan of Merger, referred to as the "amended and restated merger agreement," with Carmike Cinemas, Inc., referred to as "Carmike," and]
